What Happened?
A number of stocks fell in the afternoon session after Bloomberg reported that Anthropic’s preliminary second-quarter revenue topped $11.5 billion.
CNBC reported earlier in August, that Salesforce and its peers “have been under pressure on the view that tools such as Anthropic’s Claude Code and OpenAI’s Codex could hollow out software bills.” The market reaction suggests Anthropic’s print was treated as evidence that the tools are generating real dollars, not just demos.
Software had already bounced since Microsoft’s July 22 results, according to Morningstar, which left the group exposed if that fear returned. Salesforce, expected to report earnings later in August, could show whether customers are still expanding applications, or shifting budget to AI assistants.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.
Among others, the following stocks were impacted:
- Data Analytics company Health Catalyst (NASDAQ: HCAT) fell 7%. Is now the time to buy Health Catalyst? Access our full analysis report here, it’s free.
- Developer Operations company GitLab (NASDAQ: GTLB) fell 4.5%. Is now the time to buy GitLab? Access our full analysis report here, it’s free.
- Data Infrastructure company Elastic (NYSE: ESTC) fell 3.9%. Is now the time to buy Elastic? Access our full analysis report here, it’s free.
- Payments Software company Marqeta (NASDAQ: MQ) fell 3.8%. Is now the time to buy Marqeta? Access our full analysis report here, it’s free.
Zooming In On Health Catalyst (HCAT)
Health Catalyst’s shares are extremely volatile and have had 53 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 10 days ago when the stock dropped 23.1% on the news that the company provided a weak third-quarter revenue forecast and lowered its full-year outlook, despite topping second-quarter revenue expectations.
For the upcoming third quarter, Health Catalyst expects revenue of $55.5 million, a sharp sequential decline from the $70.49 million reported for the second quarter, which itself was down 12.7% year over year. The company also reduced its full-year 2026 revenue guidance to $247.5 million at the midpoint, a 5.7% decrease from its previous forecast.
This bleak outlook overshadowed the second-quarter results, in which the company's adjusted earnings per share met analysts' estimates, signaling significant challenges ahead.
Health Catalyst is down 25.2% since the beginning of the year, and at $1.71 per share, it is trading 53.8% below its 52-week high of $3.69 from August 2025. Investors who bought $1,000 worth of Health Catalyst’s shares 5 years ago would now be looking at only $33.43.
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
